共 50 条
- [41] UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG) EJSO, 2021, 47 (02): : 199 - 210
- [43] The management of breast implant-associated anaplastic large cell lymphoma in the setting of pregnancy: seeking for clinical practice guidelines ARCHIVES OF PLASTIC SURGERY-APS, 2021, 48 (04): : 373 - 377
- [44] European Attitudes and Outcomes Regarding Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Multinational Survey Aesthetic Plastic Surgery, 2020, 44 : 1387 - 1395
- [49] Current status of breast implant-associated anaplastic large cell lymphoma in South Korea JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2021, 64 (01): : 5 - 9
- [50] Brentuximab vedotin as monotherapy for unresectable breast implant-associated anaplastic large cell lymphoma CLINICAL CASE REPORTS, 2019, 7 (05): : 1003 - 1006